RedHill Biopharma Ltd. (RDHL)
NASDAQ: RDHL
· Real-Time Price · USD
1.88
0.03 (1.62%)
At close: May 19, 2025, 3:57 PM
1.87
-0.27%
After-hours: May 19, 2025, 05:03 PM EDT
RedHill Biopharma Revenue Breakdown
| Period Ending | Dec 31, 2024 |
|---|---|
| Movantik Revenue | 900K |
| Movantik Revenue Growth | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 8.06M | 10.91M | 13.02M | 13.6M | 17.04M | 20.38M | 17.57M | 23.96M | 25.47M | 20.99M | 24.33M | 20.74M | 16M | 13.59M | 10.29M | 7.82M | 6.55M | 5.16M | 5.04M | 4.72M | 5.14M | 5.09M | 6.36M | 6.45M | 5.32M | 1.92M | 1.6M | 1.42M | 1.16M | 1.23M | 1.71M | 692K | 801K | 927K |
| Selling, General, and Administrative Revenue Growth | -26.10% | -16.20% | -4.28% | -20.20% | -16.39% | +15.99% | -26.68% | -5.93% | +21.34% | -13.72% | +17.28% | +29.67% | +17.69% | +32.09% | +31.64% | +19.42% | +26.84% | +2.40% | +6.78% | -8.14% | +0.86% | -19.86% | -1.41% | +21.28% | +176.88% | +20.30% | +12.71% | +21.65% | -5.13% | -28.41% | +147.69% | -13.61% | -13.59% | n/a |
| Research and Development Revenue | 1.25M | 1.08M | 1.13M | 1.61M | 1.47M | 3.06M | 5.87M | 5.82M | 10.33M | 7.48M | 6.19M | 4.32M | 3.21M | 2.77M | 2.28M | 2.8M | 6.97M | 5.37M | 5.78M | 6.62M | 6.04M | 6.42M | 8.29M | 8.11M | 8.43M | 8.14M | 7.5M | 7.04M | 6.03M | 4.68M | 4.95M | 3.9M | 5.09M | 3.83M |
| Research and Development Revenue Growth | +15.04% | -4.32% | -29.71% | +9.51% | -51.93% | -47.82% | +0.86% | -43.67% | +38.00% | +20.92% | +43.16% | +34.51% | +16.24% | +21.49% | -18.69% | -59.85% | +29.78% | -7.03% | -12.77% | +9.60% | -5.80% | -22.62% | +2.29% | -3.89% | +3.65% | +8.55% | +6.51% | +16.70% | +28.98% | -5.55% | +26.92% | -23.36% | +32.93% | n/a |
| Sales and Marketing Revenue | 4.52M | 5.11M | -19.87M | 7.09M | 9.27M | 12.56M | -33.27M | 15.53M | 15.23M | 13.89M | -24.28M | 13.41M | 9.96M | 9.01M | -7.8M | 4.89M | 4.15M | 3.14M | -6.59M | 3.04M | 3.12M | 3.17M | 3.84M | 4.19M | 3.38M | 605K | 417K | 402K | 424K | 312K | n/a | n/a | n/a | n/a |
| Sales and Marketing Revenue Growth | -11.51% | -125.72% | -380.08% | -23.50% | -26.17% | -137.75% | -314.30% | +1.90% | +9.64% | -157.24% | -280.98% | +34.62% | +10.64% | -215.49% | -259.40% | +17.96% | +32.24% | -147.60% | -316.71% | -2.66% | -1.48% | -17.53% | -8.24% | +24.08% | +458.02% | +45.08% | +3.73% | -5.19% | +35.90% | n/a | n/a | n/a | n/a | n/a |